N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
about
N-acetylcysteine in COPD: why, how, and when?Positioning new pharmacotherapies for COPDAttenuation of cigarette smoke-induced airway mucus production by hydrogen-rich saline in ratsNAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functionsDepletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteineN-acetylcysteine instead of theophylline in patients with COPD who are candidates for elective off-pump CABG surgery: Is it possible in cardiovascular surgery unit?The role of N-acetylcysteine in the management of acute and chronic pulmonary complications of sulfur mustard: a literature review.Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.Pathophysiology, research challenges, and clinical management of smoke inhalation injury.N-Acetylcysteine supplementation alleviates intestinal injury in piglets infected by porcine epidemic diarrhea virus.Intraductal papillary mucinous neoplasm of the bile duct with gastric and duodenal fistulas.Proteomic and genetic analysis of the response of S. cerevisiae to soluble copper leads to improvement of the antimicrobial function of cellulosic copper nanoparticles.Oral N-acetylcysteine and exercise tolerance in mild chronic obstructive pulmonary disease.Airway Mucus and Asthma: The Role of MUC5AC and MUC5B.Effects of N-acetylcysteine on amphetamine-induced sensitization in mice.Effect of Salt-Bromide-Iodine Thermal Water Inhalation on Functional and Biochemical Lung Parameters
P2860
Q26768289-0CF4F58C-45D5-40BA-B754-65B4C325D1A2Q26798659-31CE7D6A-387F-4849-BEBE-40685873578BQ28537865-4262325C-0022-4E1F-B70C-EBD4A02ED7DBQ35108652-12F89580-C40E-4607-AE88-0588D0C87E12Q36177465-846CFDCC-702A-4A51-8F08-E98AE023ACB4Q36545154-47564B24-8924-4FA8-AFF0-ADD812202587Q37080747-C1985F1A-0077-4CFF-A259-536592C32941Q38233230-94E2D7BE-2EAE-4F4A-B3C4-275B7FEB15A4Q38240136-E4DD541B-FA7A-4312-8838-15A738D9E9E1Q38814534-55133CAD-8B1F-4C59-A90C-184F7E622011Q40309100-0842AC8A-287E-4680-805F-9F2647340B9BQ42703117-F504ECDE-9B14-4246-A40E-69125DF304FCQ45066478-CE0B4128-49F5-42D4-BD4C-A0D58A39F03BQ46410080-1ACCB15B-53B8-4C3D-AAD0-98966A7FB0F0Q48217556-604E9D92-3299-46F2-9D85-3349D411635CQ52686931-63B585CF-3477-4AAB-AC28-774407FB57F9Q58691176-490F6E2B-0929-40EF-9E81-3CD05437EC96
P2860
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@en
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@nl
type
label
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@en
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@nl
prefLabel
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@en
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@nl
P2860
P356
P1476
N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
@en
P2093
Anna M Sadowska
P2860
P304
P356
10.1177/1753465812437563
P577
2012-02-23T00:00:00Z